FAQ · about the operator
Plain answers about Conceptual Healthcare Corporation.
What is Conceptual Healthcare Corporation?
A Florida C-corporation headquartered in Destin, Florida (720 Harbor Blvd, Destin, FL 32541). Filed with the Florida Department of State, Division of Corporations. We operate the Master Equation™ ecosystem and the eleven Conceptual Health® properties, all built in-house and capitalized entirely from the founders' personal funds.
Are you publicly traded?
No. Conceptual Healthcare Corporation is privately held by its two founders and capitalized entirely from their personal funds. We have not filed with the SEC, sold securities, or qualified any offering. A future Reg-A+ raise is on the founders' long-arc roadmap; a traditional IPO is far further out and only relevant if the operating story warrants it.
Are HCR or HCC publicly tradeable as securities?
No. HCR and HCC are commodity-class digital assets earned through clinical or data-economy activity. They are not registered as securities and are not marketed as investments. Operator equity is the investable instrument; the coins are not.
How does the operator make money?
Three revenue lines. (1) Provider subscription — clinics and health systems pay for Clinical, Provider AI, and Guardian Orb™ licensing. (2) Network fees — small per-transaction fees on hc.exchange and on HCC contract settlement; published rate card on chain. (3) Researcher access — institutions pay for Datavault enclave compute and bandwidth on top of HCR contract pricing (which goes to patients, not us). We do not make money by minting HCR or HCC for ourselves.
If you got acquired, would the chain go with you?
No. The Trust Council charter is a separate legal instrument; the chain's validators are 11 independent institutions; an acquirer would acquire one of 11 validator seats, not the chain. To take chain governance, an acquirer would have to convince 9 of 13 Council seats to amend the charter — a public, deliberative, 120-day process. Detail on the governance page.
Who decides whether a Master Equation axis is valid?
The Trust Council, with input from external clinical advisors. New axes or evidence types are proposed publicly, debated, and ratified by 9-of-13. The current eight-axis composition has not changed since 2022; the evidence-type catalog is updated quarterly with new device attestations and lab integrations.
How do you handle clinical errors and AI hallucinations?
The Patient Safety committee oversees the Provider AI hallucination metric (false claims caught in clinician review, per encounter). It is published quarterly. Material incidents are reported to the FDA where relevant; if and when SEC filing obligations apply (post Reg-A+), they would also be reported on form 1-U. Provider AI never auto-finalizes a note; clinician review is mandatory.
What's your patent strategy?
Patent 63/921,717 covers the Master Equation methodology. We license to network participants under standard terms. We do not enforce against academic research, public-interest replication studies, or competing systems that don't claim Master Equation equivalence.
How do you handle subpoenas and government requests?
Process is published in our trust center. Subpoenas land on operator-side records; the chain itself is fully public. We notify affected users where lawfully permitted.
Where can I find financials?
Disclosures page — today shows the pre-funding posture (no SEC filings on record, founder-funded). Future Reg D / Reg-A+ filings will appear here as they occur. Investor letters become quarterly once outside capital is in.
Are you hiring?
Yes — quietly, and on a small team. Founder-funded means we hire only when the work is shovel-ready. Open roles, including the C-suite, live on the careers page and the C-suite roster.